Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|June 27, 2012
Oncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosumJan Brun, Douglas J Mahoney, Fabrice Le Boeuf, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysisFethia Ben Yebdri, Julien Van Grevenynghe, Vera A Tang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
Identification of genetically modified Maraba virus as an oncolytic rhabdovirusJan Brun, Dan McManus, Charles Lefebvre, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunityAnthony T Power, Jiahu Wang, Theresa J Falls, et al.
Oncotarget|December 15, 2016
Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine modelChristine C Dobson, Thet Naing, Shawn T Beug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamideXue Qing Lun, Ji-Hyun Jang, Nan Tang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2013
Maraba virus as a potent oncolytic vaccine vectorJonathan G Pol, Liang Zhang, Byram W Bridle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2007
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flowCaroline J Breitbach, Jennifer M Paterson, Chantal G Lemay, et al.
Molecular Cell|April 2, 2003
An integrated stress response regulates amino acid metabolism and resistance to oxidative stressHeather P Harding, Yuhong Zhang, Huiquing Zeng, et al.
Cancer Cell|October 31, 2003
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F Stojdl, Brian D Lichty, Benjamin R tenOever, et al.
Pageof 4